Development of a disease activity index for the assessment of reactive arthritis (DAREA)

Eberl, Gérard; Studnicka-Benke, Andrea; Hitzelhammer, H; Gschnait, F; Smolen, Josef S.

doi:10.1093/rheumatology/39.2.148

Cited by 67 publications

(53 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Although other composite disease activity measures have been proposed for use in PsA, including composite measures developed for RA (18) and reactive arthritis (19), none included evaluation of joints, skin, enthesitis, and patient-reported outcomes. When considering criteria that can be used as a target for treatment, it is imperative that all aspects of disease are considered to ensure that patients are not undertreated.…”

Section: Discussionmentioning

confidence: 99%

Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data

Coates¹,

Helliwell²

2010

Arthritis Care & Research

217

132

View full text Add to dashboard Cite

Objective. New criteria for minimal disease activity (MDA) in psoriatic arthritis (PsA) have been developed. The aim is to provide further validation of these criteria using data obtained in interventional trials with infliximab, a drug with proven efficacy in PsA. Methods. The data were obtained from patients in phase II and III infliximab studies of PsA. In both studies, patients with active PsA were treated with infliximab (5 mg/kg) or placebo followed by a period of treatment with infliximab. Between-group comparisons in terms of those achieving MDA and the relationship of MDA to American College of Rheumatology outcomes, C-reactive protein levels, and radiologic progression were performed.

show abstract

Section: Discussionmentioning

confidence: 99%

Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data

Coates¹,

Helliwell²

2010

Arthritis Care & Research

217

132

View full text Add to dashboard Cite

show abstract

“…These indices are based on a recently developed simple disease activity index for reactive arthritis (DAREA), which consists of an arithmetical sum of five core set variables [12].…”

Section: Discussionmentioning

confidence: 99%

“…Several previous studies showed SDAI as a valid and sensitive assessment of disease activity and treatment response, when compared with DAS28-ESR and ACR response criteria [7][8][9]. SDAI is easy to calculate and is a viable tool for day-to-day clinical assessments of RA treatment [12]. Aletaha et al [7] found that SDAI and CDAI had concurrent validity and were highly predictive of a change in therapy.…”

Section: Discussionmentioning

confidence: 99%

Evaluation of disease activity indices in Korean patients with rheumatoid arthritis

et al. 2011

View full text Add to dashboard Cite

The aim of this study is to examine the validity of the rheumatoid arthritis (RA), disease activity score (DAS), 28-C-reactive protein (CRP), the simplified disease activity index (SDAI), and the clinical disease activity index (CDAI) against the DAS28-erythrocyte sedimentation rate (ESR) and determine cut-off values for each tool in Korean patients with RA. A total of 223 RA patients were consecutively recruited from the Hanyang University Hospital for Rheumatic Diseases in Seoul, Korea. DAS28-CRP, SDAI, and CDAI were measured and compared with DAS28-ESR. The correlation coefficients of DAS28-ESR with DAS28-CRP, SDAI, and CDAI were 0.93, 0.85, and 0.84, demonstrating strong linear relationships. The cut-off values of DAS28-CRP classifying RA patients into four categories of disease activity were defined as 2.19, 2.60, and 4.07. SDAI cut-off values were defined as 3.75, 7.50, and 16.88. CDAI cut-off values were defined as 3.62, 7.38, and 16.50. DAS28-CRP, SDAI, and CDAI are valid and sensitive assessment indices of disease activity that are comparable to DAS28-ESR. The cut-off values of each tool derived in this study might be useful for routine monitoring and therapeutic decision-making in Korean RA patients.

show abstract

“…7 NellDuxneuner et al 18 investigated the suitability of disease activity indices in patients with PsA and identified three major headings which contained five different components: (i) patient-related data (PaGA and patient pain assessment), (ii) jointrelated data (the number of tender and swollen joints), and (iii) acute phase reactants (CRP levels showed disease activity the best). These five components are reflected more thoroughly by the DAREA.…”

Section: Discussionmentioning

confidence: 99%

“…The Disease Activity Score including 28 joints (DAS28), 4 the Disease Activity Score for Reactive Arthritis (DAREA), 7 and the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) 8 indices were used to assess the disease activity of the patients, and the Health Assessment Questionnaire (HAQ) 9 was applied for functional assessment. The results of the visual analog scale for pain (VAS-pain) (0-100 mm), patient global assessment (PaGA) and physician global assessment (PhGA) were also recorded.…”

mentioning

confidence: 99%

Disease Activity and Related Variables in Patients with Psoriatic Arthritis

et al. 2014

View full text Add to dashboard Cite

Development of a disease activity index for the assessment of reactive arthritis (DAREA)

Abstract: DAREA constitutes a reliable score which can easily be assessed on a day-to-day office work basis.

Cited by 67 publications

References 19 publications

Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data

Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data

Evaluation of disease activity indices in Korean patients with rheumatoid arthritis

Disease Activity and Related Variables in Patients with Psoriatic Arthritis

Contact Info

Product

Resources

About